High Intensity Statin Therapy/Branded
active(Clinical Focus: The intent of this value set is to represent SBD and BPCK high intensity statin medications as defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.),(Data Element Scope: RxNorm SBD and BPCK high intensity statin medications as defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.),(Inclusion Criteria: Semantic branded drugs (SBD) and semantic branded drug packs (BPCK) codes that represent high intensity statin medications defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol, along with medications that include simvastatin 80 mg, as that exceeds the dosage threshold for moderate intensity (20-40 mg) and low intensity (10 mg) simvastatin medications.),(Exclusion Criteria: Semantic clinical drugs (SCD) and semantic clinical drug packs (GPCK) RxNorm codes that represent high intensity statin medications, along with any RxNorm codes that represent moderate or low intensity statin medications. Liquid statin medications are also excluded (e.g., Simvastatin 4 mg/ml and Simvastatin 8 mg/ml) since the dosage is not specific.)
| Code | Display | System |
|---|---|---|
| 750239 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 750235 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 750207 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1245449 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 750211 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 262095 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 750215 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 859753 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 617320 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 859421 | http://www.nlm.nih.gov/research/umls/rxnorm |